# US 2018/0021319 A1 · Compositions and methods for treating gastrointestinal infections

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021319 A1
- Document ID: US20180021319A1
- Status: Published application
- Kind: A1
- Application number: 15/542,282
- Filed: 2016-01-08
- Published: 2018-01-25
- Earliest claimed: 2015-01-09
- Assignees: The Regents of the University of California; The United States Government as represented by the Department of Veterans Affairs
- Applicants: The Regents of the University of California; The United States Government Represented by the Department of Veterans Affairs
- Inventors: George Sachs; Joseph R. Pisegna; David R. Scott; Elizabeth A. Marcus
- Web page: https://patentgrep.com/patent/US20180021319A1

## CPC

- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 31/43: Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula [IMAGE cpc-sch-A61K-0952.gif], e.g. penicillins, penems
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 31/04: Antibacterial agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention described herein provides compositions and methods for treating or preventing Helicobacter pylori infection.

## Claims

### Claim 1

A composition comprising an antibiotic and a compound having the structure:
or a salt, ester, or prodrug thereof.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the antibiotic is a β-lactam antibiotic.

### Claim 3 (depends on 2)

The composition according to claim 2, wherein the β-lactam antibiotic is amoxicillin.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the composition is provided as a capsule formulated for simultaneous release of the compound and the antibiotic.

### Claim 5

A method of treating or preventing a Helicobacter pylori infection in a subject in need thereof, comprising: conjointly administering to the subject an antibiotic and a compound having the structure:
or a salt, ester, or prodrug thereof.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the antibiotic is a β-lactam antibiotic.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the β-lactam antibiotic is amoxicillin.

### Claim 8 (depends on 5)

The method according to claim 5, wherein the compound and the antibiotic are administered simultaneously.

### Claim 9 (depends on 8)

The method of claim 8, wherein the antibiotic and the compound are administered in a capsule formulated for simultaneous release of the compound and the antibiotic.

### Claim 10

(canceled)
